Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice.

about

Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice.

Item

http://www.wikidata.org/entity/Q47385024

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Peroxisome proliferator activa ...... nduced oral mucositis in mice.

@en

Peroxisome proliferator activa ...... nduced oral mucositis in mice.

@nl

type

Item

label

Peroxisome proliferator activa ...... nduced oral mucositis in mice.

@en

Peroxisome proliferator activa ...... nduced oral mucositis in mice.

@nl

prefLabel

Peroxisome proliferator activa ...... nduced oral mucositis in mice.

@en

Peroxisome proliferator activa ...... nduced oral mucositis in mice.

@nl

P1476

Peroxisome proliferator activa ...... nduced oral mucositis in mice.

@en

P2093

Chiara Gerini

http://www.w3.org/2001/XMLSchema#string

Daniela Greto

http://www.w3.org/2001/XMLSchema#string

Francesca Castiglione

http://www.w3.org/2001/XMLSchema#string

Giampaolo Biti

http://www.w3.org/2001/XMLSchema#string

Giulia Salvatore

http://www.w3.org/2001/XMLSchema#string

Giulio Francolini

http://www.w3.org/2001/XMLSchema#string

Lorenzo Livi

http://www.w3.org/2001/XMLSchema#string

Mauro Loi

http://www.w3.org/2001/XMLSchema#string

Roberta Grassi

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Chemotherapy and chemoprevention by thiazolidinediones

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patients - a triple blinded randomized controlled trial.

Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.

Radiation induced oral mucositis: a review of current literature on prevention and management.

PPARgamma as a new therapeutic target in inflammatory bowel diseases

Comparison of laser and ozone treatments on oral mucositis in an experimental model.

P304

577-583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HED.25017

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29155481

http://www.w3.org/2001/XMLSchema#string